Medreleaf Fiscal Year 2017 just published, impressiveMedreleaf -Sales of $40.3 million, EBITDA +$13.9 million. Market cap half of Canopy. Opinions?
https://investors.medreleaf.com/press-releases/press-release-details/2017/MedReleaf-Reports-Fourth-Quarter-and-Fiscal-Year-2017-Results/default.aspx
Fiscal Year 2017 Highlights
Sales of $40.3 million, an increase of 109% from the prior year
Adjusted Product Contribution Margin of $30.9 million, an increase of 159% from the prior year
Adjusted EBITDA of positive $13.9 million, an increase of 200% from the prior year
Cash cost per gram produced of $1.73 compared to $3.23 in the prior year
First Canadian Licensed Producer to bring cannabis capsules to market
etc, etc see link for more
https://investors.medreleaf.com/press-releases/press-release-details/2017/MedReleaf-Reports-Fourth-Quarter-and-Fiscal-Year-2017-Results/default.aspx